C12N 15/64
General methods for preparing the vector, for introducing it into the cell
Official title: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
C12N15/64 (General methods for preparing the vector, for introducing it into the cell) appears on 593 US grants and 814 published applications in this corpus.
Search patents in C12N- Granted patents
- 593
- Published applications
- 814
- Assignees
- 489
- Inventors
- 1,633
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 4 | 0 |
| 1992 | 9 | 0 |
| 1993 | 11 | 0 |
| 1994 | 12 | 0 |
| 1995 | 7 | 0 |
| 1996 | 9 | 0 |
| 1997 | 16 | 0 |
| 1998 | 21 | 0 |
| 1999 | 14 | 0 |
| 2000 | 17 | 0 |
| 2001 | 24 | 4 |
| 2002 | 24 | 28 |
| 2003 | 24 | 33 |
| 2004 | 10 | 43 |
| 2005 | 11 | 20 |
| 2006 | 11 | 23 |
| 2007 | 10 | 17 |
| 2008 | 7 | 12 |
| 2009 | 10 | 36 |
| 2010 | 5 | 25 |
| 2011 | 6 | 29 |
| 2012 | 15 | 18 |
| 2013 | 15 | 29 |
| 2014 | 17 | 27 |
| 2015 | 16 | 39 |
| 2016 | 19 | 36 |
| 2017 | 24 | 34 |
| 2018 | 22 | 35 |
| 2019 | 26 | 43 |
| 2020 | 27 | 63 |
| 2021 | 21 | 46 |
| 2022 | 24 | 38 |
| 2023 | 24 | 34 |
| 2024 | 26 | 43 |
| 2025 | 28 | 40 |
| 2026 | 12 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fc-binding protein having improved acid stability, production method for said protein, and antibody-adsorbing agent using said protein6 Oct 2026US 12,753,235 B2Tosoh Corporation
- VHH-containing heavy chain antibody and production thereof7 Jul 2026US 12,673,984 B2Universitätsklinikum Hamburg-Eppendorf
- Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system23 Jun 2026US 12,661,412 B2University of Massachusetts
- Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers16 Jun 2026US 12,653,851 B2Hangzhou Converd Co., Ltd.
- Intraluminal stents for treating benign prostatic hyperplasia16 Jun 2026US 12,655,445 B2Rivermark Medical, Inc.
- Rna-guided nucleases and active fragments and variants thereof and methods of use3 Sep 2026US 2026/0258452 A1Life Edit Therapeutics, Inc.
- Respiratory vectors and uses thereof20 Aug 2026US 2026/0242803 A1Aldevron, LLC
- Mutant vsvg and targeting vector13 Aug 2026US 2026/0234198 A1Shenzhen Genocury Biotech Co., Ltd.
- Systems and methods for scalable transfection reagent preparation13 Aug 2026US 2026/0234644 A1Corning Incorporated
- Method for producing recombinant adeno-associated viral vector and packaging/production cell13 Aug 2026US 2026/0234666 A1Shenzhen Eureka biotechnology Co. Ltd
Most cited
By later US patents
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- Surface expression libraries of heteromeric receptors586US 5,698,426 AIxsys, Inc. · 1997
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination531US 6,117,679 AMaxygen, Inc. · 2000
- Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof519US 5,723,323 A1998
- End-complementary polymerase reaction471US 5,928,905 AAffymetrix, Inc. · 1999